RxDoctor Payments Data

Jack Shohet, MD

Otology & Neurotology · Newport Beach, CANPI 1346325180

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Med-el Corporation at 29.8% of the total. Reporting peaked in 2023 at $448 and has fallen 52.2% since, to $214 in 2025.

$2,258in general payments, 2019–2025

Across 40 payments — averaging $56.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$673
  • Medtronic$523
  • Intersect ENT, Inc.$334
  • Cochlear Americas$236
  • Johnson & Johnson$120
  • Iotamotion, Inc.$101
  • plus $272 from 10 others

What the payments were for

  • Food & beverage$2,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,258 in reported general payments places this provider in the 55th percentile of 43 otology & neurotology providers in California.

See all otology & neurotology providers in California

Medicare billing

Part B allowed, 2024
$401,361
Medicare patients
1,067
Services billed
3,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth37$3,549
Fluocinolone Acetonide Oil26$826
Fluticasone Propionate34$687
Ipratropium Bromide16$623
Azelastine Hcl34$599
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid48$385
Ofloxacin13$328
Mometasone Furoate15$131
Prednisone13$75
Ciprofloxacin Hcl11$61
Meclizine Hcl18$55

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →